<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04159480</url>
  </required_header>
  <id_info>
    <org_study_id>18-2844</org_study_id>
    <nct_id>NCT04159480</nct_id>
  </id_info>
  <brief_title>Facilitating Assessment of At-Risk Sailors Using Technology</brief_title>
  <acronym>FAAST</acronym>
  <official_title>Facilitating Assessment of At-Risk Sailors Using Technology</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>VA Eastern Colorado Health Care System</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Colorado - Anschutz Medical Campus</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Military Suicide Research Consortium</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>VA Eastern Colorado Health Care System</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Randomized clinical trial with individuals being allocated to experimental (Cogito Companion)
      or Active Control arms. Those in the latter will receive information regarding widely
      available mobile self-help apps via a custom mobile app built in MyCAP. This same platform
      will be used to collect data regarding symptoms. Randomization will be stratified by gender,
      force (Surface, Aviation), and smartphone model (Android, I-Phone), as Cogito algorithms
      differ based on smartphone platforms. Participants will be willing Naval personnel being
      redeployed to CONUS. Data is also being collected (feasibility/acceptability) to inform
      future implementation..
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 5, 2019</start_date>
  <completion_date type="Anticipated">March 29, 2021</completion_date>
  <primary_completion_date type="Anticipated">March 29, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Randomized Clinical Trial</intervention_model_description>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
    <masking_description>Outcomes measures will be collected electronically</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Psychological Distress</measure>
    <time_frame>After the 3 month interventional period</time_frame>
    <description>Outcome Questionnaire-45</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time to Treatment Engagement During Study Period</measure>
    <time_frame>After the 3 month interventional period</time_frame>
    <description>Review of Electronic Medical Records and Self Report</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Treatment Sessions Attended</measure>
    <time_frame>After the 3 month interventional period</time_frame>
    <description>Review of Electronic Medical Record and Self Report</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Depressive Symptoms</measure>
    <time_frame>After the 3 month interventional period</time_frame>
    <description>Changes on the Patient Health Questionnaire-9</description>
  </other_outcome>
  <other_outcome>
    <measure>Post Traumatic Symptoms</measure>
    <time_frame>After the 3 month interventional period</time_frame>
    <description>Changes on the PTSD Checklist for DSM-5</description>
  </other_outcome>
  <other_outcome>
    <measure>Suicidal Ideation</measure>
    <time_frame>After the 3 month interventional period</time_frame>
    <description>Changes on the Beck Suicide Ideation Scale and Columbia-Suicide Severity Rating Scale Screener; C-SSRS Screener</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">750</enrollment>
  <condition>Psychological Distress</condition>
  <arm_group>
    <arm_group_label>Experimental - Cogito Companion</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Those allocated to Experimental arm will have access the Cogito Companion for a three-month period post-consent. Passive data collection will also occur during this period. As a secure, privacy-compliant mobile app, the Cogito Companion facilitates the non-invasive collection, transfer, integration, analysis, and reporting of objective behavioral indicators. The Cogito mobile sensing platform passively gathers behavioral information through an individual's normal smartphone usage. Measurements of location, call, and text patterns are recorded.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Active Control</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants randomized to the Active Control group will download MyCAP and have access to resources housed within this app for a three-month period post-consent. Participants will be provided information regarding the mHealth Tool apps, and provided basic information on how to download the apps. As noted above, participants will be provided biweekly surveys .</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Experimental - Cogito Companion</intervention_name>
    <description>Cogito Companion</description>
    <arm_group_label>Experimental - Cogito Companion</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Active Control</intervention_name>
    <description>Use of MyCAP</description>
    <arm_group_label>Active Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria.

          -  Member of the Navel Surface or Aviation Forces;

          -  Age: 18-55 years at the time of enrollment;

          -  Ability to provide verbal and electronic informed consents;

          -  Ownership of smartphone;

          -  Willingness to use smartphone and personal data plan to participate.

        Exclusion Criteria.

          -  Having redeployed (returning to the Continental United States) more than twelve months
             (approximately) prior to consent.

          -  Having an iPhone (until later in 2019 when the Cogito Corporation plans to release the
             iOS version of the Cogito Companion app).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lisa Brenner, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>VA/University of Colorado</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Kelly Stearns-Yoder, MA</last_name>
    <phone>729-723-6477</phone>
    <email>Kelly.Stearns@va.gov</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Lisa Brenner, Ph.D.</last_name>
    <phone>720-878-2243</phone>
    <email>lisa.brenner@va.gov</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Colorado</name>
      <address>
        <city>Aurora</city>
        <state>Colorado</state>
        <zip>80045</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lisa Brenner, Ph.D.</last_name>
      <phone>303-724-4588</phone>
      <email>lisa.2.brenner@cuanschutz.edu</email>
    </contact>
    <contact_backup>
      <last_name>Kelly Stearns</last_name>
      <phone>(720 ) 723-6477</phone>
      <email>kelly.stearns@va.gov</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2019</verification_date>
  <study_first_submitted>October 30, 2019</study_first_submitted>
  <study_first_submitted_qc>November 7, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">November 12, 2019</study_first_posted>
  <last_update_submitted>December 23, 2019</last_update_submitted>
  <last_update_submitted_qc>December 23, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">December 24, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>VA Eastern Colorado Health Care System</investigator_affiliation>
    <investigator_full_name>Lisa Brenner</investigator_full_name>
    <investigator_title>Director, Rocky Mountain MIRECC</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

